Formulary Chapter 15: Anaesthesia - Full Chapter
|
15.01 |
General anaesthesia |
|
|
15.01.01 |
Intravenous anaesthetics |
|
|
Methohexital
|
Unlicensed

|
|
|
|
Thiopental
(injection)
|
Formulary

|
|
|
15.01.01 |
Other intravenous anaesthetics |
|
|
Etomidate
(injection)
|
Formulary

|
|
|
Ketamine
(injection)
|
Formulary

|
- 200mg in 20ml vial
- 500mg in 10ml vial
|
|
Propofol
(injection)
|
Formulary

|
- 200mg in 20ml amp
- 500mg in 50ml vial
- 1g in 100ml vial
|
|
15.01.02 |
Inhalational anaesthetics |
|
|
15.01.02 |
Volatile liquid anaesthetics |
|
|
Desflurane
|
Formulary

|
|
|
Isoflurane
|
Formulary

|
|
|
Sevoflurane
|
Formulary

|
|
|
|
Nitrous oxide
|
Formulary

|
- Nitrous oxide cylinders size D, E, G
|
MHRA safety notice Nitrous oxide: neurological and haematological toxic effects Dec 2014
|
Nitrous oxide 50% with oxygen 50%
(Entonox ®)
|
Formulary

|
- Nitrous oxide 50% with oxygen 50% (Entonox) cylinders size D,F,G
- Note: MHRA safety notice Neurological and haematological toxic effects can occur with prolonged use of nitrous oxide. Neurological effects can occur without preceding overt haematological changes.
Assessment of vitamin B12 levels should be considered before nitrous oxide anaesthesia in people with risk factors for deficiency.
|
MHRA safety notice Nitrous oxide: neurological and haematological toxic effects Dec 2014
|
15.01.03 |
Antimuscarinic drugs |
|
|
|
- Please see the palliative care section for information and traffic light status relevent to use in palliative care.
|
|
Atropine Sulphate
(injection)
|
Formulary
|
 for use within secondary care
 very rarely some GPs need to use this for emergencies in primary care.
- 600 micrograms in 1ml amp
- 1mg in 1ml amp
- 1mg in 10ml PFS
|
|
Glycopyrronium Bromide
(injection)
|
Formulary

|
- 200 micrograms in 1ml amp
- 600 micrograms in 3ml amp
|
|
Hyoscine Hydrobromide
(injection)
|
Formulary

|
- 400 micrograms in 1ml amps
|
|
15.01.04 |
Sedative and analgesic peri-operative drugs |
|
|
15.01.04.01 |
Benzodiazepines |
|
|
|
- This section covers the use of benzodiazepines as a pre-medication prior to surgery and procedures.
- See chapter 4 for other use of benzodiazepines.
- See relevent seperate chapter for traffic light status for use in palliative care.
|
|
Diazepam
(injection)
|
Formulary

|
- 10mg in 2ml Injection (emulsion - Diazemuls®)
|
|
Lorazepam
(injection)
|
Formulary

|
|
SPS memo Oct 2020 - Shortage of Ativan (lorazepam) Injection 4 mg in 1 ml
|
Midazolam
(injection)
|
Formulary

|
- 5mg in 5ml injection
- 10mg/2ml injection
|
|
Temazepam
(oral)
|
Formulary

|
- Tablets 10mg, 20mg
- Oral solutionSF 10mg in 5ml prohibitively expensive (Aug 19)
- Notes:
- Loprazolam & temazepam both have short duration of action and have no active metabolites.
- Temazepam is a Schedule 3 controlled drug; a maximum of 30 days supply for all controlled drugs is the good practice advice from the Department of Health. Ref: Safer Management of Controlled Drugs, May 2007
|
|
15.01.04.01 |
Benzodiazepines |
|
|
15.01.04.02 |
Non-opioid analgesics |
|
|
Ketorolac
(injection)
|
Formulary

|
- 30mg in 1ml amp
- Licensed for use in short-term management of moderate to severe post operative pain only.
- Contains a small amount of ethanol per dose (100mg)
- See palliative care section Chapter 21
|
|
15.01.04.03 |
Opioid analgesics |
|
|
Alfentanil
(injection)
|
Formulary

|
- 1mg in 2ml amp
- 5mg in 10ml amp
- 5mg in 1ml amp intensive care injection
- Note - also included as an AMBER TLS drug in SWINDON ONLY for use in palliative care. See here
|
|
Fentanyl
(Injection)
|
Formulary

|
- 100 micrograms in 2ml amp
- 500 micrograms in 10ml amp
|
|
Remifentanil
(injection)
|
Formulary

|
- 1mg vial
- 2mg vial
- 5mg vial
|
|
15.01.04.04 |
Other drugs for sedation |
|
|
Dexmedetomidine
(IV)
|
Formulary

|
- GWH ICU/theatres only
- 100 micrograms/ml concentrate for solution for infusion, various ampoule sizes
|
|
15.01.05 |
Neuromuscular blocking drugs |
|
|
15.01.05 |
Non-depolarising muscle relaxants |
|
|
Atracurium Besilate
(injection)
|
Formulary

|
- 25mg in 2.5ml amp
- 50mg in 5ml amp
- 250mg in 25ml vial
|
|
Cisatracurium
(Injection)
|
Formulary

|
- SFT only
- 2mg/ml or 5mg/ml
|
|
Mivacurium
(IV)
|
Formulary

|
- GWH only
- Injection 2 mg/ml
|
|
Pancuronium
(injection)
|
Formulary

|
|
|
Rocuronium
(injection)
|
Formulary

|
|
|
Vecuronium
(IV)
|
Formulary

|
|
|
15.01.05 |
Depolarising muscle relaxants |
|
|
Suxamethonium Chloride
(injection)
|
Formulary

|
|
|
15.01.06 |
Drugs for reversal of neuromuscular blockade |
|
|
15.01.06 |
Anticholinesterases |
|
|
Neostigmine
(injection)
|
Formulary

|
|
|
Neostigmine with Glycopyrronium
(injection)
|
Formulary

|
- 500 micrograms in 1ml amp
|
|
15.01.06 |
Other drugs for reversal of neuromuscular blockade |
|
|
Sugammadex
(injection)
|
Formulary

|
- 100mg/ml injection 1ml, 2ml or 5ml vials
|
|
15.01.07 |
Antagonists for central and respiratory depression |
|
|
Flumazenil
(injection)
|
Formulary

|
- 500 micrograms in 5ml amp
- Used to reverse the effects of benzodiazepines. See SPC for full information on safe use.
|
|
Naloxone
(injection)
|
Formulary

|
|
NHSE Patient safety alert: Risk of Distress and Death from inappropriate doses of naloxone
|
15.01.08 |
Drugs for malignant hyperthermia |
|
|
Dantrolene Sodium
(injection)
|
Formulary

|
|
|
|
|
Bupivacaine and Adrenaline
(injection)
|
Formulary

|
- 0.25% w/v
- 0.5% w/v
- 1 in 200,000
|
|
Bupivacaine Hydrochloride
(injection)
|
Formulary

|
- 25mg in 10ml (0.25%) amp
- 50mg in 10ml (0.5%) amp
- 75mg in 10ml (0.75%) amp
- GWH only: 0.1% and 0.125% epidural infusion bags used.
|
|
Bupivacaine Hydrochloride with Glucose
(injection)
|
Formulary

|
- 0.5% solution for injection, 4ml ampoule
- Not routinely stocked at RUH
|
|
15.02 |
Levobupivacaine |
|
|
Levobupivacaine
(injection)
|
Formulary

|
- 25mg in 10ml (0.25%) amp
- 50mg in 10ml (0.5%) amp
|
|
Levobupivacaine with Fentanyl
(IV)
|
Formulary

|
|
|
|
Lidocaine
(Xylocaine)
(Spray 10%)
|
Formulary

|
- SFT only
- This product is non-sterile and therefore not recommended for use prior to procedures that require aseptic techniques
- Lidocaine 10 mg/metered dose.
- Used for the prevention of pain related to specific procedures
- Contains ethanol
- 50 ml glass spray bottles (approx. 500 spray doses) with a metering spray pump.
|
|
Lidocaine 2.5% with Prilocaine 2.5%
(EMLA®)
(cream)
|
Formulary

|
- Lidocaine 2.5%, Priolocaine 2.5%, 30g, 5g with dressings
|
|
Lidocaine 5% and Phenylephrine 0.5%
(spray)
|
Formulary

|
- Each bottle contains 2.5ml of solution to be used as a spray, equivalent to 125mg lidocaine and 12.5mg phenylephrine hydrochloride.
|
|
Lidocaine Hydrochloride
(injection)
|
Formulary

|
- 50mg in 10ml (0.5%) vial
- 20mg in 2ml (1%) amp
- 50mg in 5ml (1%) amp
- 200mg in 20ml (1%) amp
- 200mg in 20ml (1%) vial preserved
- 100mg in 5ml (2%) amp
- 100mg in 5ml (2%) prefilled syringe
- 400mg in 20ml (2%) amp
|
|
Lidocaine with Adrenaline
(injection)
|
Formulary
|
- Xylocaine 1% with adrenaline 1:200,000 multi-dose vial, 20ml and xylocaine 2% with adrenaline 1:200,000 multidose vial, 20ml.
 for use in acute trusts
 for use by GPs in primary care undertaking minor procedures/surgery
 for GWH only: Lidocaine dental cartridges -Lignospan Special® (Lidocaine hydrochloride 2% + adrenaline 1:80000).
|
|
Lidocaine2% with Chlorhexidine 0.25%
(Instillagel®)
|
Formulary

|
- Lidocaine 20mg/ml and chlorhexidine gluconate 500mcg/ml. 60ml or 110ml
|
|
|
Prilocaine Hydrochloride
(injection)
|
Formulary

|
- Spinal anaesthesia 20mg/ml for injection, 5ml ampoule
|
|
Prilocaine Hydrochloride with Felypressin
(injection)
|
Formulary

|
- 54mg (3%) with felypressin 0.03 units/ml 1.8ml cartridges
|
|
Prilocaine (+ glucose)
(Prilotekal®)
(IV)
|
Formulary

|
- GWH only
- Due to the glucose content Prilotekal is only to be used for spinal anaesthesia. It is not recommended for the use in epidural anaesthesia.
|
|
|
Tetracaine (Amethocaine)
(Ametop®)
(gel)
|
Formulary

|
|
|
15.02 |
Other local anaesthetics |
|
|
Articaine Hydrochloride with Adrenaline
(injection)
|
Formulary

|
- Articaine hydrochloride 40mg/ml, adrenaline 1 in 100,000 (10 micrograms/ml), 2.2ml cartridge for dental use
|
|
Cocaine HCl
(Solution 10% w/v)
|
Formulary

|
- GWH only
- Sterile oromucosal solution 10%
- For topical use only. Not for injection or to be taken.
- Cocaine Hydrochloride Solution is indicated to provide local anaesthesia and vasoconstriction of accessible mucous membranes prior to surgery especially in the oral, laryngeal, and nasal cavities.
|
|
Ethyl Chloride
(Spray)
|
Formulary

|
- 100ml
- CAUTION: Extremely flammable liquified gas under pressure. Stable at room temperature 8ºC-20ºC. Use only with good ventilation. Avoid use near electrical equipment, naked flames or high temperature surfaces. Store in a metal cupboard in a ventilated room- never in a refridgerator. All empty or unused containers must be returned to pharmacy for destruction.
|
|
Ropivacaine hydrochloride
(Injection)
|
Formulary

|
- SFT only
- 2mg/ml, 7.5mg/ml or 10mg/ml
|
|
Cocaine 5% with adrenaline 1:2000
(Topical gel)
|
Unlicensed

|
|
|
.... |
Non Formulary Items |
Benzocaine

|
Non Formulary
|
|
|
Benzocaine 20% Gel
(Ultracare® Bubble Gum)

|
Non Formulary
|
|
|
Bupivacaine with Fentanyl

|
Non Formulary
|
|
|
Dermogesic spray

|
Non Formulary
|
|
|
Doxapram
(Dopram®)

|
Non Formulary
|
|
|
Edrophonium

|
Non Formulary
|
|
|
Lidocaine
(laryngojet®)

|
Non Formulary
|
|
|
Lidocaine 4% cream
(LMX4®)

|
Non Formulary
|
|
|
Lidocaine with Adrenaline
(Lignospan®)

|
Non Formulary
|
|
|
Lidocaine with Prilocaine
(Fortacin®)

|
Non Formulary
|
|
|
Lidocaine with tetracaine
(Pliaglis®)

|
Non Formulary
|
|
|
Lignocaine

|
Non Formulary
|
|
|
Mepivacaine
(Scandonest Plain®)

|
Non Formulary
|
|
|
Naloxone pre-filled syringes
(Prenoxad®)

|
Non Formulary
|
|
|
Parecoxib
(Dynastat®)

|
Non Formulary
|
|
|
|
Key |
|
|
Cytotoxic Drug
|
|
Controlled Drug
|
|
High Cost Medicine
|
|
Cancer Drugs Fund
|
|
NHS England |
|
Homecare |
|
CCG |
|
High Cost Drug Approval System |
|
Traffic Light Status Information
|
|
|